OPERATING ACTIVITIES: | |
Net income | 189M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Gain on sale of assets | |
Change in fair value of contingent consideration | |
Accelerated amortization of term loan financing fees | |
Stock compensation expense | 16.67M |
Excess tax benefit of stock options exercised | 0 |
Depreciation | 94.08M |
Amortization | 102.31M |
Deferred income taxes | |
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures: | |
Accounts receivable | -26.83M |
Accounts payable | 681K |
Accrued liabilities | 6.14M |
Deferred revenues | -1.23M |
Other assets and liabilities | 18.66M |
Net cash provided by operating activities | |
INVESTING ACTIVITIES: | |
Payments for acquisitions and international investments, net of cash acquired | |
Purchase of short-term investments | |
Proceeds from sale of assets | |
Capital expenditures | -100.98M |
Net cash used in investing activities | |
FINANCING ACTIVITIES: | |
Repayment of long-term debt | -68.21M |
Borrowings on senior credit facility | 1.21B |
Repayments on senior credit facility | -1.12B |
Payments of deferred consideration | |
Payments on capital lease obligations | -4.64M |
Purchase/ cancellation of treasury stock | -40.81M |
Proceeds from other issuance of common stock | 35.73M |
Excess tax benefit of stock options exercised | 0 |
Net cash provided by/ (used in) financing activities | |
Effect of exchange rate changes on cash | 2.32M |
Net decrease in cash and cash equivalents | -15.34M |
Cash and cash equivalents at beginning of period | 55.63M |
Cash and cash equivalents at end of period | 40.29M |
NON-CASH ACTIVITIES: | |
Net issuance of notes payable for certain acquisitions |